Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Enhanced Stability Body Protection Compound
Weekly Protocol Guide
BPC-157 Arginate Protocol Guide
BPC-157 Arginate is the L-arginine salt form of Body Protection Compound-157, offering enhanced stability compared to the acetate salt. It is studied for gastric and tissue protection, wound healing acceleration, and tendon/ligament repair. The arginate form may also be taken orally for gut-related research applications with improved bioavailability.
Protocol Overview
- Compound
- BPC-157 Arginate (BPC-157 L-Arginine Salt Form)
- Category
- Enhanced Stability Body Protection Compound
- Vial Size
- 10mg (10,000mcg)
- Reconstitution
- 2mL bacteriostatic water (5mg/mL)
- Route
- Subcutaneous injection
- Frequency
- 7 days/week
Reconstitution Instructions
Using 2mL of bacteriostatic water results in a concentration of 5mg/mL. The arginate salt form provides enhanced stability. Always use sterile techniques.
Materials Needed
- 10mg BPC-157 Arginate 10mg vial (lyophilized powder)
- 2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
- Sterile syringe and needle (18-22 gauge for drawing)
- Alcohol swabs
- Clean workspace
Step-by-Step Process
- Preparation: Allow the BPC-157 Arginate 10mg vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
- Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles.
- Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
- Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
- Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.
Weekly Dosing Schedule
| Day | Units | Dose | Timing |
|---|---|---|---|
| Monday | 5 | 250mcg | Morning |
| Tuesday | 5 | 250mcg | Morning |
| Wednesday | 5 | 250mcg | Morning |
| Thursday | 5 | 250mcg | Morning |
| Friday | 5 | 250mcg | Morning |
| Saturday | 5 | 250mcg | Morning |
| Sunday | 5 | 250mcg | Morning |
Weekly Total: 35 units (1,750mcg) • Vial Duration: ~29 days
Quick Dosing Reference
| Units (Ticks) | Dose (mcg) | Dose (mg) |
|---|---|---|
| 2 | 100 | 0.1mg |
| 5 | 250 | 0.25mg |
| 10 | 500 | 0.5mg |
| 20 | 1000 | 1mg |
| 50 | 2500 | 2.5mg |
Administration Guidelines
- Administer subcutaneously or orally once daily
- For subQ, rotate injection sites between abdomen, thigh, and upper arm
- Inject near area of injury when possible for localized research
- For oral use, draw dose into syringe and squirt into mouth (hold under tongue for 60 seconds)
- Store reconstituted peptide refrigerated at 36-46F (2-8C)
- Use reconstituted solution within 30 days
- Never freeze reconstituted peptides
- Document administration route, times, and observations
Storage Requirements
| State | Storage Conditions |
|---|---|
| Lyophilized (powder) | Room temperature or refrigerated, protect from light |
| Reconstituted | Refrigerated 36-46F (2-8C), use within 30 days |